{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Pointe-Claire",
      "state": "N/A",
      "country": "Canada",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78887",
      "recalling_firm": "Odan Laboratories Ltd",
      "address_1": "325 Stillview Ave",
      "address_2": "N/A",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "distributed nationwide in the USA",
      "recall_number": "D-0231-2018",
      "product_description": "Day Cream SPF15 Cr¿me de jour FPS 15, { Avobenzone 2%, Octinoxate 7%,  Oxybenzone 5%} 15 ml / 0.5 fl. oz jar. Made in Canada, Kamins Dermatologics Inc. Montreal, Quebec H9R 2Y6. Distributed by Kamins Dermatologics Montreal, Quebec H9R 2Y6 Made in Fabrique au Canada. UPC code  6 26354 10955 0",
      "product_quantity": "21 jars",
      "reason_for_recall": "Failed Stability Specifications:stability failure at 12 months, long term RT conditions.",
      "recall_initiation_date": "20171220",
      "center_classification_date": "20180124",
      "termination_date": "20180618",
      "report_date": "20180131",
      "code_info": "Lot # J146C, EXP 02-2019."
    }
  ]
}